Literature DB >> 27271491

Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohn's Disease.

Amit Assa1, James Butcher, Jennifer Li, Abdul Elkadri, Philip M Sherman, Aleixo M Muise, Alain Stintzi, David Mack.   

Abstract

BACKGROUND: The composition of the intestinal microbiome seems relevant to the pathogenesis of Crohn's disease (CD), with differences in both diversity and composition of the gut microbiota in patients with CD compared with healthy individuals. However, there are still conflicting reports on the importance of various bacterial taxa in the pathogenesis of CD. The aim of this study was to characterize the composition of mucosa-associated intestinal microbiota in newly diagnosed pediatric patients with CD.
METHODS: Mucosa-associated bacteria were identified from ileal biopsy specimens obtained at colonoscopy of 10 patients with either ileal or ileocolonic new-onset CD and 15 controls without mucosal inflammation. Microbial composition was performed by profiling the 16S rDNA V6 region using Illumina sequencing. Samples were analyzed for differences in alpha/beta diversity and also for differentially abundant taxa.
RESULTS: Alpha diversity did not differ between the controls and CD cases or between CD subjects with localized ileal disease compared with those with more extensive disease. Controls also did not clearly separate from patients with CD by principal coordinate analyses; however, 117 operational taxonomic units were found to be differentially abundant between the two groups. In particular, numerous operational taxonomic units associated with Faecalibacterium prausnitzii species were increased in children with CD.
CONCLUSIONS: These findings contribute to emerging evidence regarding dysbiosis in pediatric CD, and provide additional evidence challenging the protective role of F. prausnitzii in CD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27271491     DOI: 10.1097/MIB.0000000000000776

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  15 in total

Review 1.  Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease.

Authors:  M N Quraishi; W Shaheen; Y H Oo; T H Iqbal
Journal:  Clin Exp Immunol       Date:  2019-11-27       Impact factor: 4.330

Review 2.  Role of Selenoproteins in Bacterial Pathogenesis.

Authors:  Sarah E Sumner; Rachel L Markley; Girish S Kirimanjeswara
Journal:  Biol Trace Elem Res       Date:  2019-09-05       Impact factor: 3.738

Review 3.  Gut microbiota and IBD: causation or correlation?

Authors:  Josephine Ni; Gary D Wu; Lindsey Albenberg; Vesselin T Tomov
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-07-19       Impact factor: 46.802

4.  The gut microbiota of siblings offers insights into microbial pathogenesis of inflammatory bowel disease.

Authors:  Charlotte R Hedin; Christopher J van der Gast; Andrew J Stagg; James O Lindsay; Kevin Whelan
Journal:  Gut Microbes       Date:  2017-01-23

5.  High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis.

Authors:  Ilaria Cosorich; Gloria Dalla-Costa; Chiara Sorini; Roberto Ferrarese; Maria Josè Messina; Jayashree Dolpady; Elisa Radice; Alberto Mariani; Pier Alberto Testoni; Filippo Canducci; Giancarlo Comi; Vittorio Martinelli; Marika Falcone
Journal:  Sci Adv       Date:  2017-07-12       Impact factor: 14.136

6.  Low-complexity microbiota in the duodenum of children with newly diagnosed ulcerative colitis.

Authors:  Fei Sjöberg; Cecilia Barkman; Intawat Nookaew; Sofia Östman; Ingegerd Adlerberth; Robert Saalman; Agnes E Wold
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

Review 7.  Cellular Stress Responses and Gut Microbiota in Inflammatory Bowel Disease.

Authors:  Siyan Stewart Cao
Journal:  Gastroenterol Res Pract       Date:  2018-06-20       Impact factor: 2.260

8.  Microbiota profile in new-onset pediatric Crohn's disease: data from a non-Western population.

Authors:  Mohammad I El Mouzan; Harland S Winter; Assad A Assiri; Kirill S Korolev; Ahmad A Al Sarkhy; Scot E Dowd; Mohammad A Al Mofarreh; Rajita Menon
Journal:  Gut Pathog       Date:  2018-11-29       Impact factor: 4.181

9.  Fecal transplantation for treatment of inflammatory bowel disease.

Authors:  Aamer Imdad; Maribeth R Nicholson; Emily E Tanner-Smith; Joseph P Zackular; Oscar G Gomez-Duarte; Dawn B Beaulieu; Sari Acra
Journal:  Cochrane Database Syst Rev       Date:  2018-11-13

10.  Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease.

Authors:  Xu Zhang; Shelley A Deeke; Zhibin Ning; Amanda E Starr; James Butcher; Jennifer Li; Janice Mayne; Kai Cheng; Bo Liao; Leyuan Li; Ruth Singleton; David Mack; Alain Stintzi; Daniel Figeys
Journal:  Nat Commun       Date:  2018-07-20       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.